Football Players Health Study In Person Assessments Study

NCT03866564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2024-05-08

No results posted yet for this study

Summary

The aim of the Football Players Health Study (FPHS) is to advance the understanding of the complex and inter-related pathways that can develop into player related illness and disability. Former National Football League players will be given the opportunity to undergo 2\&1/2 days of rigorous assessment in the areas of Cardiac Dysfunction, Neurocognitive Disease, Chronic Pain, and Sleep Apnea to attempt to define the pathology among former professional athletes.

Conditions

Interventions

DIAGNOSTIC_TEST

Echocardiography

Cardiac ultrasound to measure left ventricular systolic function.

DIAGNOSTIC_TEST

Neuropsychological Testing

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

DIAGNOSTIC_TEST

Quantitative Sensory Testing

Clinically accepted quantitative assessment of chronic pain burden.

DIAGNOSTIC_TEST

Nocturnal Polysomnography

Routine overnight sleep study to measure apnea-hypopnea index.

Sponsors & Collaborators

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER
  • Beth Israel Deaconess Medical Center

    collaborator OTHER
  • Martinos Center for Biomedical Imaging

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Meagan M Wasfy, MD, MPH · Massachusetts General Hospital

Eligibility

Min Age
24 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-22
Primary Completion
2022-11-30
Completion
2022-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866564 on ClinicalTrials.gov